Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

The Cooper Companies Inc's Business Segments

The Cooper Companies Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of Q1 FY2026
Reportable Segments
2
Per the company's own filing, this quarter
Largest Segment
CooperVision
67.9% of revenue
Total Revenue
$ 1,023
Consolidated, this quarter
Regions Reported
2
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/COO/segments
https://api.csimarket.com/api/v1/companies/COO/geographic
https://api.csimarket.com/api/v1/companies/COO/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - Q1 FY2026

68%largest
  • CooperVision67.9%
  • CooperSurgical32.2%

Revenue by Reportable Segment - Q1 FY2026

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
CooperVisionQ1 FY2026$ 69567.9%-
CooperSurgicalQ1 FY2026$ 32932.2%-

Revenue Share by Region - Q1 FY2026

32%largest
  • Europe31.9%
  • Rest of World, Excluding United States and Europe18%

Revenue by Geographic Region - Q1 FY2026

RegionPeriodRevenue
(Millions)
% of Total
EuropeQ1 FY2026$ 32631.9%
Rest of World, Excluding United States and EuropeQ1 FY2026$ 18418%

Revenue by Product & Service Category - Q1 FY2026

34%largest
  • Toric and Multifocal34.3%
  • Sphere, Other33.6%
  • Office and Surgical19.8%
  • Fertility12.4%

Revenue by Product & Service Category - Q1 FY2026

CategoryPeriodRevenue
(Millions)
% of Total
Toric and MultifocalQ1 FY2026$ 35134.3%
Sphere, OtherQ1 FY2026$ 34433.6%
Office and SurgicalQ1 FY2026$ 20219.8%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

1 more categories available

Sign in to unlock the full The Cooper Companies Inc dataset.

Description of The Cooper Companies Inc

The Cooper Companies Inc. is a prominent American medical device company specializing in the fields of ophthalmology and fertility. Founded in 1958 by Martin Cooper under the name Cooper Laboratories, the company initially focused on producing contact lenses. Over the decades, The Cooper Companies has evolved significantly, growing its operations and establishing a presence in more than 100 countries globally.

Business Segments

The Cooper Companies operates primarily through two distinct segments: CooperVision and CooperSurgical.

CooperVision

CooperVision is dedicated to producing a wide array of vision care products, particularly contact lenses. The company is recognized for its innovative advancements in contact lens technology, offering various types of lenses to cater to diverse vision needs. Key product offerings include:

- Soft Contact Lenses: Developed for daily comfort.
- Silicone Hydrogel Lenses: Known for their breathability and moisture retention.
- Toric Lenses: Designed specifically for individuals with astigmatism.
- Multifocal Lenses: Aimed at correcting presbyopia.
- Lens Care Solutions: Products designed to maintain lens hygiene and eye health.

The companys flagship brands include Biofinity, Avaira, Proclear, and Clariti, which are established names in the eyecare industry and noted for their quality and effectiveness in addressing various eye conditions such as myopia and astigmatism.

CooperSurgical

In the fertility sector, CooperSurgical develops and provides medical devices and consumables designed to assist couples in conceiving, particularly through assisted reproductive technologies (ART), including in-vitro fertilization (IVF). The CooperSurgical segment has established itself as a market leader, with a significant presence in key markets such as the United States, Europe, and Japan.

The product range within CooperSurgical includes innovative solutions designed to improve success rates in reproductive health, thereby addressing the increasing global demand for fertility treatments.

Strategic Growth and Acquisitions

The Cooper Companies has a history of strategic acquisitions aimed at enhancing its product portfolio and expanding its market reach. Key acquisitions include:

- In 2014, the company acquired Sauflon Pharmaceuticals, a UK-based manufacturer of contact lenses, bolstering its presence in the European market.
- In 2017, the company acquired the assets of Teva Pharmaceutical’s global women’s health business, significantly broadening its footprint in the women’s health sector and enhancing its offerings in fertility-related products.

Customer Base and Distribution

The Cooper Companies caters to a diversified customer base that includes eye care professionals, hospitals, clinics, and retail outlets. The company also operates an e-commerce platform, allowing patients to purchase contact lenses directly from them and enhancing customer accessibility to their products.

Global Operations

Headquartered in San Ramon, California, The Cooper Companies boasts a robust global infrastructure with manufacturing and distribution facilities strategically located in the United States, Europe, and Asia. As of recent reports, The Cooper Companies employs over 12,000 individuals worldwide, reflecting its commitment to innovation and customer service in the medical device landscape.

Financial Performance

The company has consistently demonstrated strong financial performance, with revenues reflecting its growth and expansion efforts. In FY2020, The Cooper Companies reported revenues of approximately $2.6 billion, underscoring its position as a leading entity in both the ophthalmology and fertility sectors.

Through its focus on innovation, strategic acquisitions, and dedication to serving its diverse global customer base, The Cooper Companies continues to reinforce its status as a vital player in the medical device industry, particularly in vision care and reproductive health.
The Cooper Companies Inc. operates primarily through two distinct business units: CooperVision and CooperSurgical, each of which specializes in different facets of healthcare, addressing unique medical and vision care needs. Here is an extensive breakdown of the segments, products, and services offered by the company:

CooperVision

CooperVision is dedicated to the design, production, and distribution of a comprehensive range of innovative contact lens solutions, focusing on advanced technologies that cater to various vision correction needs. Their offerings are categorized as follows:

1. Contact Lens Types:
- Daily Disposable Lenses:
- MyDay: These lenses utilize Aquaform technology, ensuring optimal hydration and comfort while delivering exceptional visual clarity that lasts throughout the day.
- Clariti: Focused on breathability, Clariti lenses provide a high level of comfort and come equipped with UV protection, making them ideal for active lifestyles.

- Monthly Replacement Lenses:
- Biofinity: Renowned for its Water Gradient technology, Biofinity lenses are designed for extended wear, enabling users to maintain comfort even during prolonged use, with options available for continuous overnight wear.
- Avaira: These lenses offer a unique combination of comfort and high oxygen permeability, supporting eye health on a two-week replacement schedule.

- Toric Lenses (for Astigmatism):
- Proclear Toric: Designed explicitly for astigmatic patients, Proclear Toric lenses provide stable and consistent vision while utilizing a moisture-rich formula to keep the lenses hydrated, enhancing overall comfort.

- Multifocal Lenses:
- Biofinity Multifocal: Catered for presbyopia, these lenses enable users to enjoy clear vision at all distances—near, intermediate, and far—without sacrificing comfort or clarity.

- Myopia Management:
- MiSight: This lens represents a breakthrough in pediatric eye care, specifically designed as a daily disposable option to help slow the progression of myopia in children, underscoring CooperVisions commitment to advancing eye health from a young age.

Specialized Technologies:
- CooperVision invests significantly in research and development to bring forth lenses developed with advanced materials like silicone hydrogel, enhancing oxygen flow and maintaining corneal health.
- The company promotes sustainability through initiatives aimed at reducing the environmental footprint of their products and production processes.

CooperSurgical

CooperSurgical focuses on providing an extensive array of medical devices and solutions to enhance womens health and fertility care. Their offerings can be grouped into several categories:

1. Medical Devices for Gynecology:
- Surgical Instruments:
- A wide range of high-quality instruments essential for gynecological surgery, including colposcopes, electrosurgical units, and specialized manipulators for uterine procedures.

- Colposcopy Products:
- High-definition colposcopes and related accessories facilitate comprehensive examination and treatment of cervical conditions, enhancing diagnostic accuracy.

- Electrosurgical Instruments:
- These instruments help achieve precision and efficiency in minimally invasive gynecological surgeries, improving surgical outcomes.

Fertility Solutions:
- CooperSurgical plays a vital role in reproductive medicine, offering products for in-vitro fertilization (IVF) and assisted reproductive technologies:
- Oocyte Retrieval Systems: Designed to optimize the egg retrieval process during IVF, ensuring higher success rates.
- Embryo Transfer Catheters: Precision-designed for enhanced embryo transfer procedures, contributing to improved implantation success.
- Culture Media: Specialized media for embryo development, ensuring the best environment for embryonic growth.

Genetic Testing and Screening:
- Through its division CooperGenomics, the company provides advanced genetic testing solutions that support informed reproductive choices:
- Preimplantation Genetic Testing (PGT) is available to assess embryos for genetic conditions prior to implantation, improving outcomes in assisted reproductive procedures.
- Carrier screening tests allow couples to understand their genetic risks for inherited disorders, informing family planning decisions.

Patient Care Solutions:
- CooperSurgical also offers various services to enhance patient care, such as:
- Prenatal Testing: Advanced tests for checking maternal and fetal health during pregnancy, enabling proactive healthcare management.
- HPV Testing: Diagnostic tools for the early detection of human papillomavirus, aiding in cervical cancer prevention strategies.
- Gynecological Specimen Collection Products: Tools designed to facilitate effective and accurate specimen collection for clinical assessments.

Summary

The Cooper Companies Inc. is committed to enhancing patient care and advancing professional practices in healthcare through its two primary business units, CooperVision and CooperSurgical. CooperVision offers innovative solutions in eye care, while CooperSurgical provides essential medical devices and services focusing on womens health and fertility. The company’s dedication to research, technology, and comprehensive service delivery underscores its commitment to high-quality care and the continuous advancement of healthcare solutions, positioning itself as a significant player in the medical devices and healthcare marketplace.